The Therapeutic Potential of Nuclear Receptor Modulators for Treatment of Metabolic Disorders: PPARγ, RORs, and Rev-erbs

Nuclear receptors (NRs) play central roles in metabolic syndrome, making them attractive drug targets despite the challenge of achieving functional selectivity. For instance, members of the thiazolidinedione class of insulin sensitizers offer robust efficacy but have been limited due to adverse effe...

Full description

Saved in:
Bibliographic Details
Published in:Cell metabolism 2014-02, Vol.19 (2), p.193-208
Main Authors: Marciano, David P., Chang, Mi Ra, Corzo, Cesar A., Goswami, Devrishi, Lam, Vinh Q., Pascal, Bruce D., Griffin, Patrick R.
Format: Article
Language:English
Subjects:
Adipose Tissue, Brown - metabolism
Animals
Circadian Rhythm - physiology
Humans
Metabolic Syndrome - metabolism
PPAR gamma - metabolism
Receptors, Cytoplasmic and Nuclear - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nuclear receptors (NRs) play central roles in metabolic syndrome, making them attractive drug targets despite the challenge of achieving functional selectivity. For instance, members of the thiazolidinedione class of insulin sensitizers offer robust efficacy but have been limited due to adverse effects linked to activation of genes not involved in insulin sensitization. Studies reviewed here provide strategies for targeting subsets of PPARγ target genes, enabling development of next-generation modulators with improved therapeutic index. Additionally, emerging evidence suggests that targeting the NRs ROR and Rev-erb holds promise for treating metabolic syndrome based on their involvement in circadian rhythm and metabolism.
ISSN:1550-4131
1932-7420
DOI:10.1016/j.cmet.2013.12.009